Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years to discover which of them develop cancer and which, if any, experience survival benefit ...
Jan 8, 2013
0
0
Almost always deadly and steadily on the rise, pancreatic cancer is on track to become the second-leading cause of cancer death in the nation within the next two years, according to a recent report.
Dec 7, 2012
0
0
Dogs are surprisingly adept at sniffing out lung cancer, results from a pilot project in Austria published on Wednesday suggested, potentially offering hope for earlier, life-saving diagnosis.
Dec 5, 2012
0
0
Medical physicists at Thomas Jefferson University and Jefferson's Kimmel Cancer Center are one step closer to bringing a new tumor-tracking technique into the clinic that delivers higher levels of radiation to moving tumors, ...
Nov 19, 2012
0
0
There are substantial inequalities in the stage at which cancer patients receive their diagnosis – a critical factor for cancer survival – a new study by the University of Cambridge reveals. The researchers found that ...
Nov 12, 2012
0
0
Early signs of lung cancer could be diagnosed using a simple blood test following a new discovery by scientists at the University of York.
Oct 15, 2012
0
0
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit ...
Oct 15, 2012
0
0
(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research over the last several ...
Oct 11, 2012
0
0
More effective treatments for one of the deadliest forms of cancer are one step closer thanks to groundbreaking research from an international collaborative study.
Oct 1, 2012
0
0
The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer, researchers said at the ESMO 2012 ...
Sep 30, 2012
0
0
